NO944577L - Hemming av effekten av amyloidogene proteiner - Google Patents
Hemming av effekten av amyloidogene proteinerInfo
- Publication number
- NO944577L NO944577L NO944577A NO944577A NO944577L NO 944577 L NO944577 L NO 944577L NO 944577 A NO944577 A NO 944577A NO 944577 A NO944577 A NO 944577A NO 944577 L NO944577 L NO 944577L
- Authority
- NO
- Norway
- Prior art keywords
- inhibition
- effect
- amyloidogenic proteins
- pperldino
- amyloldogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/160,379 US6489355B2 (en) | 1993-12-01 | 1993-12-01 | Methods of inhibiting the effects of amyloidogenic proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944577D0 NO944577D0 (no) | 1994-11-29 |
| NO944577L true NO944577L (no) | 1995-06-02 |
Family
ID=22576649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944577A NO944577L (no) | 1993-12-01 | 1994-11-29 | Hemming av effekten av amyloidogene proteiner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6489355B2 (de) |
| EP (1) | EP0663209A3 (de) |
| JP (1) | JPH07188010A (de) |
| KR (1) | KR950016720A (de) |
| CN (1) | CN1109750A (de) |
| AU (1) | AU673961B2 (de) |
| CA (1) | CA2136789A1 (de) |
| CZ (1) | CZ293194A3 (de) |
| HU (1) | HUT72297A (de) |
| IL (1) | IL111790A (de) |
| NO (1) | NO944577L (de) |
| NZ (1) | NZ270008A (de) |
| UA (1) | UA26459C2 (de) |
| ZA (1) | ZA949404B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5492927A (en) * | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
| ZA982877B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
| US5990129A (en) * | 1997-09-23 | 1999-11-23 | Eli Lilly And Company | Methods for regulating trkA expression |
| CN1305377A (zh) | 1998-06-16 | 2001-07-25 | 伊莱利利公司 | 提高乙酰胆碱水平的方法 |
| US6288108B1 (en) | 1998-06-16 | 2001-09-11 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
| EP2081892A4 (de) * | 2006-11-17 | 2014-03-05 | Donald F Weaver | Verbindungen und verfahren zur behandlung von proteinfaltungserkrankungen |
| CN108186678A (zh) * | 2018-01-10 | 2018-06-22 | 天津科技大学 | 羟基化碳纳米管在制备抑制β-淀粉样蛋白聚集的药物的用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4380635A (en) | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US5145892A (en) * | 1985-12-19 | 1992-09-08 | Chisso Corporation | Polypropylene resin composition |
| US5075321A (en) | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5081304A (en) * | 1988-09-22 | 1992-01-14 | Warner-Lambert Company | Isotopically-labeled polycyclic amine derivatives |
| US4960815A (en) * | 1988-09-22 | 1990-10-02 | Warner-Lambert Company | Isotopically-labeled polycyclic amine derivatives |
| US5395842A (en) | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| GB9002834D0 (en) * | 1990-02-08 | 1990-04-04 | Ici America Inc | Compounds |
| FR2663934B1 (fr) * | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| US5214063A (en) * | 1990-06-27 | 1993-05-25 | Adir Et Compagnie | 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors |
| US5189041A (en) * | 1990-11-16 | 1993-02-23 | Syntex (U.S.A.) Inc. | Tricyclic 5-ht3 receptor antagonists |
| US5177074A (en) * | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5175164A (en) * | 1991-06-05 | 1992-12-29 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted indole or dihydroindole |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| US5192220A (en) * | 1992-01-31 | 1993-03-09 | Amp Inc. | Dual readout extended socket |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| US5288249A (en) * | 1992-09-02 | 1994-02-22 | Cooper Industries, Inc. | Base for cartridge lamp |
| US5252524A (en) * | 1992-10-16 | 1993-10-12 | Corning Incorporated | Polarizing glasses |
| TW383306B (en) * | 1992-12-22 | 2000-03-01 | Lilly Co Eli | New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol |
| US5552415A (en) * | 1993-12-21 | 1996-09-03 | Eli Lilly And Company | Method of inhibiting Alzheimer's Disease |
| JP4111352B2 (ja) | 1996-05-21 | 2008-07-02 | 新日鐵住金ステンレス株式会社 | ステンレス鋼の高清浄化精錬法 |
-
1993
- 1993-12-01 US US08/160,379 patent/US6489355B2/en not_active Expired - Fee Related
-
1994
- 1994-11-28 NZ NZ270008A patent/NZ270008A/en unknown
- 1994-11-28 UA UA94119085A patent/UA26459C2/uk unknown
- 1994-11-28 CA CA002136789A patent/CA2136789A1/en not_active Abandoned
- 1994-11-28 ZA ZA949404A patent/ZA949404B/xx unknown
- 1994-11-28 CZ CZ942931A patent/CZ293194A3/cs unknown
- 1994-11-28 IL IL11179094A patent/IL111790A/en active IP Right Grant
- 1994-11-29 AU AU79093/94A patent/AU673961B2/en not_active Ceased
- 1994-11-29 EP EP94308805A patent/EP0663209A3/de not_active Withdrawn
- 1994-11-29 NO NO944577A patent/NO944577L/no unknown
- 1994-11-29 KR KR1019940031649A patent/KR950016720A/ko not_active Application Discontinuation
- 1994-11-29 HU HU9403422A patent/HUT72297A/hu unknown
- 1994-11-30 JP JP6296343A patent/JPH07188010A/ja active Pending
- 1994-11-30 CN CN94112880A patent/CN1109750A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0663209A3 (de) | 1995-10-11 |
| US20010051368A1 (en) | 2001-12-13 |
| IL111790A (en) | 1998-10-30 |
| NO944577D0 (no) | 1994-11-29 |
| US6489355B2 (en) | 2002-12-03 |
| KR950016720A (ko) | 1995-07-20 |
| IL111790A0 (en) | 1995-01-24 |
| NZ270008A (en) | 1997-07-27 |
| CZ293194A3 (en) | 1995-07-12 |
| CA2136789A1 (en) | 1995-06-02 |
| JPH07188010A (ja) | 1995-07-25 |
| CN1109750A (zh) | 1995-10-11 |
| HUT72297A (en) | 1996-04-29 |
| UA26459C2 (uk) | 1999-08-30 |
| EP0663209A2 (de) | 1995-07-19 |
| AU7909394A (en) | 1995-06-08 |
| HU9403422D0 (en) | 1995-02-28 |
| AU673961B2 (en) | 1996-11-28 |
| ZA949404B (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| WO2003055441A3 (en) | Medicaments | |
| NO308248B1 (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat | |
| NO944934L (no) | Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom | |
| NO944930L (no) | Hemming av dysfunksjonell uterin blödning | |
| NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| GB9211172D0 (en) | Compounds | |
| ES2141957T3 (es) | Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. | |
| MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
| DK0659416T3 (da) | Inhibering af seborE og acne | |
| UA39941C2 (uk) | Засіб для інгібування окислення ліпопротеїну низької щільності, засіб для приглушення атеросклерозу та засіб для приглушення ішемічної хвороби серця атеросклеротичного походження | |
| DK5386D0 (da) | Arylcyklobutylaminer og laegemiddelpraeparat indeholdende en saadan forbindelse | |
| NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
| NO944923L (no) | Hemming av vektökning eller indusering av vekttap | |
| GB9215844D0 (en) | Novel compounds | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO972887L (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
| NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
| NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
| NO944917D0 (no) | Anvendelse av 2-fenyl-3-aroyltiofener for inhibering av eggstokkdysgenese, forsinket pubertet eller seksuell infantilisme | |
| ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
| NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
| NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet |